Reed Jobs's Yosemite closes $350M second fund to make cancer non-lethal
Fortune Term Sheet· Allie Garfinkle·· 2 hours agoTop DealsAI Score60
Reed Jobs's Yosemite closes $350M second fund to make cancer non-lethal
Reed Jobs’s Yosemite raises $350 million second fund to make cancer non-lethal
AI Overview
Reed Jobs's cancer-focused venture firm Yosemite closed its second fund at $350 million.
Why it matters
Yosemite's second fund doubling to $350M shows how a philanthropy-plus-venture model is being used to back cancer research, with Amgen, AbbVie and MIT among its LPs.